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Abstract
Although polymicrobial infections, caused by combinations of viruses, bacteria, fungi and parasites, are being recognised
with increasing frequency, little is known about the occurrence of within-species diversity in bacterial infections and the
molecular and evolutionary bases of this diversity. We used multiple approaches to study the genomic and phenotypic
diversity among 226 Escherichia coli isolates from deep and closed visceral infections occurring in 19 patients. We observed
genomic variability among isolates from the same site within 11 patients. This diversity was of two types, as patients were
infected either by several distinct E. coli clones (4 patients) or by members of a single clone that exhibit micro-heterogeneity
(11 patients); both types of diversity were present in 4 patients. A surprisingly wide continuum of antibiotic resistance, outer
membrane permeability, growth rate, stress resistance, red dry and rough morphotype characteristics and virulence
properties were present within the isolates of single clones in 8 of the 11 patients showing genomic micro-heterogeneity.
Many of the observed phenotypic differences within clones affected the trade-off between self-preservation and nutritional
competence (SPANC). We showed in 3 patients that this phenotypic variability was associated with distinct levels of RpoS in
co-existing isolates. Genome mutational analysis and global proteomic comparisons in isolates from a patient revealed a
star-like relationship of changes amongst clonally diverging isolates. A mathematical model demonstrated that multiple
genotypes with distinct RpoS levels can co-exist as a result of the SPANC trade-off. In the cases involving infection by a
single clone, we present several lines of evidence to suggest diversification during the infectious process rather than an
infection by multiple isolates exhibiting a micro-heterogeneity. Our results suggest that bacteria are subject to trade-offs
during an infectious process and that the observed diversity resembled results obtained in experimental evolution studies.
Whatever the mechanisms leading to diversity, our results have strong medical implications in terms of the need for more
extensive isolate testing before deciding on antibiotic therapies.
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Introduction
Polymicrobial infections, caused by combinations of viruses,
bacteria, fungi and parasites, are being recognised with increasing
frequency [1]. Polymicrobial infections due to bacteria of the same
species have been less studied, as they are clearly more difficult to
identify. However, recent molecular epidemiological tools allow
their systematic detection, as well as the study of the relatedness
between strains. Two kinds of within-species diversity have been
reported: polyclonal diversity with infection caused by phylogenet-
ically divergent clones and monoclonal diversity with infection by
members of a single clone that exhibit genetic micro-heterogeneity.
Such within-species polymicrobial infection have been reported
mainly in chronic and/or open infections (Pseudomonas aeruginosa
infections of lung in cystic fibrosis patients [2,3] and of burn wounds
[4], Helicobacter pylori gastric infection [5], Staphylococcus epidermidis
joint prosthesis infection [6] and endocarditis [7], lung tuberculosis
[8]) but also in septicemia [9,10].
Beside these clinical observations, in vitro experimental evolution
has provided some clues on the diversification process in a single
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clonal population. It has been shown that stable polymorphisms
can emerge due to ecological interactions [11,12,13,14]. More
detailed analysis of variation with larger numbers of sampled co-
evolving bacteria showed that a very complex polymorphism with
considerable phenotypic diversity could emerge in a matter of days
[15], revealing a kind of adaptive radiation. In this case, selection
under nutrient limitation altered the SPANC balance, or the
trade-off between self-preservation and nutritional competence
[16]. Polymorphisms affecting the SPANC balance often result in
altered cellular levels of the sigma factor RpoS, which results in
modification of several phenotypes, such as nutritional abilities,
general stress resistance, starvation survival, cell morphology [17].
RpoS is a central regulator of stress resistance. Strains with higher
RpoS level are more resistant to external stress but metabolised
fewer substrates whereas strains with lower RpoS level have
broader nutritional capabilities but lower resistance to external
stress. Experimental evolution has also studied cooperation and
competition among single species bacteria according to relatedness
[18]. Overall, many different ecological sources of polymorphism
have been identified in more than 60 years of bacterial
experimental evolution. Yet, few studies have connected the
molecular bases of such polymorphism to the one observed in the
course of an infection. Currently, it is impossible to distinguish
whether bacterial adaptation in the course of an infection is the
action of the immune system [19] or the kind of process observed
in in vitro experimental systems. Are the selective pressures
identified as a source of diversification in in vitro experimental
systems actually relevant during an infection?
Escherichia coli is a commensal of the intestinal tract of
vertebrates, including humans [20], that can cause intestinal
(diarrhoea) and extraintestinal [urinary tract infection (UTI),
pneumonia, neonatal meningitis, septicaemia] infections [21].
Human extraintestinal infections have high incidence and
associated morbidity, mortality (500,000 estimated deaths a year
worldwide), and costs [22]. E. coli species can be considered as
having mainly a clonal genetic structure [23,24] with four main
phylogenetic groups (A, B1, B2 and D) [25,26]. Numerous
epidemiological and animal model studies have documented the
association of specific ‘‘virulence’’ determinants and/or phyloge-
netic groups with the different clinical syndromes [21,27,28]. It is
classically admitted that E. coli extraintestinal infections are caused
by identical isolates originating from single clones. From this
assumption, the identification and antibiotic testing are mainly
based on the characterisation of a single colony from the
pathological specimen isolation. However, as for other bacterial
species [2,3,4,5,6,7,8,9,10], this assumption is questionable.
In this context, we studied the level of genomic and phenotypic
polymorphism of E. coli in human severe and closed extraintestinal
infections. The aim of our work was (i) to get a better appreciation of
the occurrence of within-species diversity in closed infections, (ii) to
decipher the molecular and evolutionary bases of this diversity and
(iii) to test, using a mathematical model, whether SPANC balancing
can be a contributing factor to the observed pathogen diversification.
Results
Two kinds of intra-patient E. coli genetic diversity were
observed: polyclonal and monoclonal with micro-
heterogeneity
To have a global distribution of the genetic diversity of the 226
E. coli isolates from 19 patients (Table 1), we used a combination of
phylogenetic grouping, multi locus sequence typing (MLST),
Enterobacterial Repetitive Intergenic Consensus (ERIC)-PCR and
pulsed field gel electrophoresis (PFGE) analyses to characterise the
two kinds of diversity, i.e. polyclonal and monoclonal with micro-
heterogeneity. Polyclonal infections were identified by distinct
sequence type and/or phylogenetic group/subgroup and unrelat-
ed ERIC-PCR and PFGE patterns whereas monoclonal infection
with micro-heterogeneity were characterised by identical sequence
type and phylogenetic group/subgroup and distinct but related
patterns of ERIC-PCR and PFGE [29].
In 8 cases (42%) corresponding to 3 UTI, 1 meningitis, 1 pleural
infection, 1 ascites, 1 placenta infection and 1 hepatic abscess
(patients 1, 2, 4, 6, 7, 9, 10 and 18), no genetic diversity was
observed (Table 1). In patients 5, 8, 15 and 16 (21%) (Table 1),
corresponding to intra-abdominal infections, polyclonal infections
were observed. In patient 16, three different clones corresponding
to 3 distinct phylogenetic groups were observed among the
isolates. In patients 8 and 15, the isolates belong to 2 different
phylogenetic group/subgroups (Table 1). In patient 5 where the
two isolates belong to the A1 subgroup (Table 1), MLST analysis
clearly showed two distinct sequence types corresponding to a
large divergence time. Among these infections, isolates exhibited
different ERIC-PCR patterns with each of the three primers (see
Fig. 1 for an example). Moreover, these 4 patients with polyclonal
infections have at least one of the clone exhibiting micro-
heterogeneity (Table 1), characterised by closely related but
different patterns observed by ERIC-PCR with only one or two
primers and by PFGE (see Fig. 1 and 2 for an example). In the
remaining 7 patients (3, 11, 12, 13, 14, 17 and 19), monoclonal
infections with micro-heterogeneity were detected by ERIC-PCR
and PFGE (Table 1). In these cases of micro-heterogeneity, the
isolates belong to the same phylogenetic group/subgroup and
sequence type using 7 essential genes as well as the sequence of the
gnd gene, one of the most variable genes in E. coli [30]. Altogether,
presence of at least a clone with micro-heterogeneity was observed
in 11 patients (58%). A dendrogram constructed from the PFGE
patterns of E. coli isolates from these patients is shown in Fig. 3A.
Within a patient, the level of similarity between isolates is above
94% (Fig. 3A). In patients 3 and 19 from which blood and an
additional sample were available, the micro-heterogeneity was
observed in both samples. Lastly, all the 19 patients were infected
by unrelated clones (Table 1 and Fig. 3A).
The presence of 20 virulence factors (VFs) known to be
associated to extra intestinal virulence [31] and representative of
the main classes of VFs (protectin, adhesin, toxin, iron uptake
Author Summary
We investigated whether an infection is a site of pathogen
within-species diversity. Our results indicate that there is
indeed extensive diversity during human extraintestinal
infections by Escherichia coli. This diversity was of two
types, not mutually exclusive, as we found that patients
were infected either by several distinct E. coli clones or by
members of a single clone that exhibit micro-heterogene-
ity. The high degree of phenotypic diversity, including
antibiotic resistance, suggests that there is no uniform
selection pressure leading to a single fitter clone during an
infection. We discuss a possible mechanism and a
mathematical model that explains these unexpected
results. Our data suggest that the evolution of diversity
in the course of an infection and in in vitro experimental
evolution in the absence of host immune selective
pressure may have many parallels. Whatever the mecha-
nisms leading to diversity, our results have strong medical
implications in terms of the need for more extensive
isolate testing before deciding on antibiotic therapies.
Within-Patient E. coli Diversity during Infections
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system) were studied. A wide range of VF patterns was observed
from the absence of detected gene in A group strains to the
presence of 12 studied genes in the B2 group strains, in agreement
with the well known link between virulence and phylogeny [27]
(data not shown). Among the 4 patients (5, 8, 15 and 16) infected
by several distinct clones, the VF patterns of each clone within a
patient were always different. In 3 patients infected by a clone
exhibiting a micro-heterogeneity (14, 17 and 19), the iucC and iutA
genes, associated to traT gene, were either present or absent,
indicating the variable presence of a plasmid bearing the
aerobactin operon (Tables 1 and S1).
In summary, a high level of genetic diversity was frequently
observed in the isolates originating from a single patient. Two
kinds of genetic diversity were observed: (i) polyclonal infection
and (ii) monoclonal infection with micro-heterogeneity. These two
kinds of genetic diversity can be combined in a single patient.
Isolates from a single clone with genetic micro-
heterogeneity exhibit variable antibiotic susceptibility
and growth patterns
We then wanted to know if the genetic micro-heterogeneity
observed within isolates of a single clone was associated with
phenotypic variation. To this purpose, we studied in all the isolates
two phenotypes having critical impact on strain fitness in an
infection, i.e. antibiotic sensitivity and growth. Among the 226 E.coli
isolates, 19 distinct antibiotypes were distinguished. We found 9
clones in 9 patients (3, 8, 11, 12, 13, 14, 16, 17 and 19) exhibiting
heterogeneity in the antibiotic resistance pattern, all of which having
a genetic micro heterogeneity (Tables 1 and S2, Fig. 3A and 4A).
The antibiotics concerned were the b-lactams, tetracycline,
streptomycin and kanamycin, the sulfonamides, trimethoprim and
chloramphenicol. Within these single clones, 2 to 4 distinct
antibiotypes were evidenced, the most sensitive phenotype being
always observed in the minority of the isolates (Table S2). Several
causes of variation in antibiotic susceptibility were likely. Firstly, loss
of genetically mobile resistance genes was confirmed by a perfect
correlation between the b-lactam resistance phenotype and the
positive TEM (b-lactamase) PCR results in the isolates from 5
patients (3, 8, 12, 16 and 19). This mechanism is also likely involved
in the loss of resistance to tetracycline, streptomycin, kanamycin,
sulfonamides, trimethoprim and chloramphenicol, as the genes
encoding for these resistances in clinical isolates are located on
mobile elements such as transposons and integrons [32]. Patients 14
and 16 are particularly illustrative of this phenomenon as multiple
combinations of antibiotic resistance losses were observed within a
Table 1. Main characteristics of the E. coli studied.
Patient IDa Origin
Number of
isolates
Phylogenetic group/
subgroupsb
Genetic micro-
heterogeneityc
Virulence factor pattern
variabilityd
Number of
antibiotypes
Growth
defecte
1 urine + blood 10+10 D1 2 1
2 urine + blood 10+10 B23 2 1
3 hepatic abscess +
blood
10+10 B23 + 2 +
4 placenta + blood 20+10 B23 2 1
5 perirectal abscess 7 A1
f (5)
A1 (2)
+
2
1
1
+
6 hepatic abscess 8 A1 2 1
7 ascitic fluid 8 D1 2 1
8 bile 7 A0 (2)
A1 (5)
+
+
1
2
9 pleural fluid 10 B22 2 1
10 cerebrospinal fluid 5 A1 2 1
11 cerebrospinal fluid 7 A0 + 2 +
12 urine 6 A1 + 2
13 urine 7 B23 + 2 +
14 pleural fluid 8 B1 + iucC, iutA, traT 4 +
15 hepatic abscess 14 B1(2)
B23 (12)
2
+
1
1 +
16 appendiceal abscess 9 A1 (1)
B1 (7)
B23 (1)
2
+
2
1
3
1
17 peritoneal fluid 9 A1 + iucC, iutA, traT 2 +
18 urine 15 B23 2 1
19 urine + blood 5+11 D1 + iucC, iutA, traT 2 +
aBold numbers correspond to patients infected by distinct clones (polyclonal infections).
bDetermined as in [63]. When several group/subgroups are present within a single patient, the number of isolates belonging to each group/subgroup is indicated in
parentheses.
cDetermined by PFGE and/or ERIC-PCR.
dOnly variable virulence factors are indicated. All these variable genes are plasmid-located.
eA plus sign indicates that some isolates within a single patient exhibit impaired growth as compared to other isolates of the same patient.
fThese two groups of A1 strains were differentiated by MLST.
doi:10.1371/journal.ppat.1001125.t001
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single patient (Table S2). Secondly, hyper-susceptibility to b-lactams
was observed in 3 patients (11, 13 and 17). We have further studied
the isolates of patient 17. Susceptibility to antibiotics (amoxicillin,
piperacillin and ticarcillin) and detergents (SDS) was not constant
and outer membrane permeability assays indicated heterogeneity in
permeation rates due to variations in porin-mediated diffusion
(Fig. 3B). Thirdly, the discrepancy between outer membrane
permeability (Fig. 3C) and antibiotic/SDS susceptibility (Fig. 3B)
points to yet other differences in envelope structure or efflux
between isolates [32], suggesting an unexpectedly extensive range of
surface variations inside a patient.
Even more strikingly, heritable variation in growth character-
istics was found amongst clonal isolates from 8 patients, all infected
by at least one clone with genetic micro-heterogeneity (Tables 1
and 2). Impaired growth was characterised by longer lag time
and/or generation time and/or reduced biomass in stationary
phase (Table 2). Within a patient, impaired growth was found in 6
to 22% of isolates (mean 13%), the remaining isolates having
identical unimpaired growth kinetics (Fig. 4B and Tables 1 and 2).
Commensal clonal populations are phenotypically less
diverse than pathogenic ones
A crucial question is whether micro-heterogeneity is due to
multiple infections of micro-evolved genotypes of the same clone
from a common route and/or source of infection or to evolution
during the infectious process. We thus compared within-clone
phenotypic diversity in the 19 populations isolated from infections
and in 15 clonal populations isolated from the faeces of 15 healthy
subjects matched for geographic origin and sex with the infected
patients (10 colonies studied per sample). We found in healthy
subjects one change of antibiotic profile within a subject, affecting
the resistance to sulfonamides in 7 isolates, and one change in
growth ability within another subject, affecting one isolate from
10. This is a significantly different pattern as compared to the
infected patients (Wilcoxon two sided test, p = 0.015), consistent
with increased genetic differentiation during infection.
Mutators are present within monoclonal isolates of a
unique patient
A way to increase the genetic and phenotypic diversity is to
increase the mutation rate. We thus measured the frequencies of
mutations conferring resistance to rifampin in the isolates of 9
patients where a strain with genetic micro-heterogeneity was
identified. In patient 14 the isolates were all resistant to rifampin.
The median value of mutagenesis for the 91 isolates from the
remaining 8 patients was 3.3361029, a value not different from
the previously reported E. coli collections [33]. Considering a
threshold of 10-fold the median value for defining mutators, 3
isolates were mutators: one in patient 3, one in patient 12 and one
among the A1 isolates in patient 17 (Table S3). Among these three
isolates, one from patient 17 displayed a .50-fold increase in
mutagenesis and was considered as a strong mutator. Such strong
mutators have been shown to be essentially mismatch repair
deficient in the wild [34].
Isolates exhibiting a micro-heterogeneity did not have a higher
mutation rate than commonly found in the species E. coli. Hence,
increased mutation rate should not be the primary cause of the
observed phenotypic diversity, yet the presence of some mutator
isolates at quite high frequency compared to their expected
production by mutation, suggests that some strong adaptation
might be under way in those populations [35].
The level of RpoS is variable within isolates of a single
clone
In environments as in the host where stress and nutritional
competition are both important, selection may well affect SPANC-
related phenotypes [15,36,37].
We studied the variability of the SPANC-related phenotypes in
the 8 patients showing differences in growth kinetics. Using an
assay that tests the metabolic capacity of a strain to use a wide
array of carbon sources (Phenotype MicroArrays) [38], we found
that isolates from a single clone within a single patient have distinct
patterns of substrate use (Fig. 4C and Tables 2 and S4).
Figure 1. Electrophoretic patterns in agarose gel of PCR products from E. coli isolates. Primers ERIC1 (A), ERIC1R (B) and ERIC2 (C) were
used for E. coli isolates of patient 5 (lanes 1 to 7). MW, DNA ladder (New England Biolabs, Saint Quentin en Yvelines, France). The banding patterns of
isolates 1 to 5 are clearly different from the banding patterns of isolates 6 and 7, whatever the primer. This corresponds to two distinct E. coli clones.
Of note, isolate 3 with primer ERIC1R (B) can be distinguished from other isolates of the same clone by one band (white circle). This corresponds to a
genetic micro-heterogeneity.
doi:10.1371/journal.ppat.1001125.g001
Within-Patient E. coli Diversity during Infections
PLoS Pathogens | www.plospathogens.org 4 September 2010 | Volume 6 | Issue 9 | e1001125
Interestingly, 9 of these substrates differentially used within isolates
from a single patient (Table S4) are among the 13 substrates whose
metabolism is stimulated by an rpoS disruption [39]. Motility and
sensitivity to H2O2 and acid were also highly variable among
isolates from a single patient (Figs 4D and E and Table 2). Thus,
heterogeneity in motility pattern was evidenced in 7 of the 8
patient isolates, with the majority of isolates within a patient being
motile and the minority being non motile whereas polymorphism
in the H2O2 and acid sensitivity was observed in all and 5 patients,
respectively. Furthermore, a significant relation was observed
between growth, capacity to use the substrates, sensitivity to H2O2
and acid and motility. Strains showing impaired growth use fewer
substrates, are more resistant to H2O2 and acid but less motile
(Fig. S1), in accordance with the proposed SPANC trade-off [39].
We also studied the development of the red dry and rough (rdar)
morphotype, which is depending of RpoS [40]. This morphotype
is a multicellular behavior characterized by expression of the
adhesive extracellular matrix components curli fimbriae and
cellulose [41]. The morphotypes within isolates of single patients
were highly variable (see Fig. 5A for an example). To confirm the
role of RpoS in the observed polymorphism, we studied in more
detail the 8 isolates of patient 3, the 7 isolates of the patient 13 and
the 9 isolates of patient 17. The level of RpoS in the cell was
assessed qualitatively by staining for presence of glycogen (RpoS
regulates positively glgA, the glycogen synthase gene) and
quantitatively by RpoS immunoblotting using specific antibodies.
Both assays were consistent and showed isolate-specific endoge-
nous levels of RpoS (Figs 5 and S2 and data not shown). Although
the variations were not drastic except for few isolates, the fact that
they were highly correlated between both techniques as well as to
the nutritional and stress phenotypes and the rdar morphotypes,
and the differentially expressed proteins for the patient 3 (see
below and Fig. 6), is an argument for their physiologic relevance.
Hence a major determinant of the polymorphism observed appear
to be linked to the SPANC balance as observed in some
experimental evolution settings.
Twenty-seven proteins are differentially expressed
within the isolates of a single clone in relation to the
SPANC-related phenotypes
To decipher the molecular bases of the RpoS phenotype, we
first sequenced the rpoS promoter and gene but surprisingly did not
detect any mutations amongst the 8 representative isolates of
patient 3. We then performed differential proteomics on these 8
isolates by bidimensional electrophoresis (2-DE) and mass
spectrometry. Twenty-seven proteins were significantly differen-
tially expressed between the isolates, with a 1.8 to 24 fold range
Figure 2. Pulsed-field gel electrophoresis resolving XbaI restriction fragments from E. coli isolates. Lines 3–7, 9, 10 and 11–13, 15–19
correspond to isolates of patients 5 and 14, respectively. Line 1, MW, DNA ladder (New England Biolabs, Saint Quentin en Yvelines, France), lines 2, 8
and 14, unrelated E. coli strain used as control. Differences between closely related strains are indicated by circles. Patient 5 was infected by two
different E. coli clones (lines 3–7 and 9,10). Banding patterns of lines 3–7 are closely related, with differences affecting only one or two bands, but
completely different from banding patterns of lines 9 and 10, which are identical. These data are in agreement with the ERIC-PCR data (Fig. 1). The
isolates of patient 14 (lines 11–13, 15–19) are closely related with seven bands being variable among all isolates.
doi:10.1371/journal.ppat.1001125.g002
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(Fig. S3 and Table 3). Among them, 16 were involved in central
metabolism, 9 were membrane proteins and 2 were stress proteins.
Furthermore, 14 out of the 27 differentially expressed proteins
were known to be RpoS regulated (Table 3). Within the 8 isolates,
the levels of the 27 proteins, except one putative outer membrane
protein, were significantly related, as well as to the level of RpoS,
the sensitivity to H2O2 and acid, the capacity to use substrates, the
motility and the growth, with one group of proteins closely linked
to the level of RpoS and the other with growth (Fig. 6).
Few mutations are associated with the phenotypic
changes observed within the isolates of a single clone
To identify the mutations responsible for these phenotypic
changes, we performed whole-genome sequencing of 4 (42, 45, 50
and 58) of these 8 isolates of the patient 3 and searched by PCR
for the identified mutations in the 4 (47, 51, 52 and 54) remaining
isolates. Six point mutations, one small deletion and one IS
insertion were identified, generating a star like phylogeny with
each of the four sequenced isolates having its own combination of
mutations (Fig. 7 and Table 4). The point mutations in 42, 45
and 58 isolates were absent from the remaining isolates in Fig. 7.
The IS insertion was only identified in two of four sequenced
isolates, but was shown by PCR to be in 47, 52 and 54 isolates as
well. The genes affected were encoding for metabolic functions,
including the acid resistance system dependent upon glutamate,
and for membrane proteins. Of note, ompA was the target of 2
different molecular defects in isolates 45 and 58 (Table 4), which
is a very strong sign of selection. A mutation in the repressor of
the rbs operon involved in the D-ribose catabolic function, was
observed. This operon was also shown to be the target of
Figure 3. Antibioresistance phenotypes of E. coli isolates. (A) Dendrogram constructed from the pulsed-field gel electrophoresis patterns of
104 isolates of E. coli showing genetic micro-heterogeneity in 12 clones infecting 11 patients with the antibiotypes. The antibiotypes are indicated
with the corresponding isolates as in Table S2. Ward’s algorithm was used to cluster the isolates from a similarity matrix created by using the band-
based Dice similarity coefficient. The stars indicate the isolates differentiated by ERIC-PCR. Patient 8 is infected by one A1 clone and one A0 clone.
Abbreviation of the antibiotypes is as follow: A, susceptible to all antibiotics tested; B, susceptible to all antibiotics tested and hyper- susceptible to b-
lactams; C, Penicillinase production; D, Penicillinase production and resistant to tetracycline (Te), minocycline (Mn), sulfonamides (Sul), streptomycin
(St), kanamycin (Ka); E, resistant to Te, Mn, Ka; F, resistant to Te, Mn, Sul, St; G, Penicillinase production and resistant to Te, Mn, Ka; H, Penicillinase
production and resistant to Te, Sul, trimethoprim (TMP), St, Ka, nalidixic acid (Na), chloramphenicol (Ch); I, resistant to Te, Sul, St, Na, Ch; J,
Penicillinase production and resistant to Te, Mn, Sul, TMP, St; K, Penicillinase production and resistant to Te, Mn, Ch; L, Penicillinase production and
resistant to Te, Mn, Sul, St, Ch; M, resistant to Sul, St; N, resistant to Te; O, resistant to Te, Sul, St. Various level of susceptibility to penicillin antibiotics
were observed among isolates of patient 17. (B) Minimum inhibitory concentration (MIC) of three b-lactams [amoxicillin (AMX), Piperacillin (PIP),
Ticarcillin (TIC)] and susceptibility to SDS of the nine isolates from patient 17. The antibiotype is as in (A). Note the heterogeneous patterns of MICs
and SDS susceptibility of the hyper-susceptible isolates to b-lactams, indicating the implication of various mechanisms of increased outer membrane
permeability. (C) Outer membrane permeability rates for the nine isolates from patient 17, compared to the rate for E. coli K-12 strain MC4100. The
permeability rate for MC4100 was 3.96, in units of optical density change at 492 nm/min/1010 bacteria.
doi:10.1371/journal.ppat.1001125.g003
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inactivating mutations selected during experimental evolution in
glucose minimal medium [42]. Most of the mutations were
corroborated by the proteomic changes in the corresponding
isolate (Table 4).
Multiple genotypes with distinct levels of RpoS can co-
exist as a result of the trade-off
Can SPANC balancing provide an explanation for E. coli
diversity observed in the clonal isolates of a single patient
described above? To test this hypothesis we consider a
mathematical model that is built on a series of simple assumptions
regarding bacterial metabolism and the environment in which
bacteria reside, but that allows us examine in isolation the role of
SPANC balancing in the creation and maintenance of diversity.
In our model we assume that E. coli isolates differ in their RpoS
expression, x, normalized to 0#x#1 so that an rpoS- mutant has
x = 0 and the rpoS+ with a maximal level of resistance has x = 1.
Evolutionary changes in x are constrained by the SPANC balance
trade-off in the following way: an increase in x leads to a decrease
in the maximal resource uptake rate denoted by a decreasing
function f(x); an increase in x also leads to an increase in the stress
protection denoted by an increasing function c(x). Next we
consider an E. coli population with n competing isolates each with a
different value of the RpoS expression x, and define Nxi to be the
density of an isolate with phenotype xi where i = 1…n and
0= x1#x2#…#xn = 1. We assume that mutations altering x occur
at a rate e taking into account both mutations in known regulators
of RpoS levels as well as mutations that pleiotropically affect the
levels of RpoS. A schematic representation of the model can be
found in Fig. S4.
Solving numerically the system of equations (1) we find that
starting with an isogenic rpoS+ population, the equilibrium
population can support two or more partial rpoS- mutants
depending on the shape of the SPANC balance trade-off namely
on the shape of f(x) and c(x) (Fig. 8). For example, if mutations,
that further decrease the levels of RpoS in a type that already
has low levels of RpoS, do not lead to a marked decrease in
stress protection (Fig. 8a), the long-term population structure
supports two genotypes with distinct RpoS levels (Fig. 8d). On
the other hand if mutations, that further decrease the levels of
RpoS in a type that already has low levels of RpoS, lead to a
clear decrease in stress protection (Fig. 8c), the long-term
population structure supports three genotypes with distinct levels
of RpoS (Fig. 8e).
Note that in our model the coexistence of multiple genotypes
requires the assumption that changing RpoS levels from 1 to 0
induces three distinct levels of stress protection (Fig. 8a and c).
While to our knowledge the shapes of the SPANC balance trade-
off have not been determined in detail these forms are not
unrealistic because stress responses to most environmental stresses
Figure 4. Illustration of the phenotypic diversity observed in the E. coli isolates of patient 3 infected by a unique clone [isolates
from blood (ID 42–50) and liver abscess (ID 51–58)]. (A) Variability in the antibiotypes with a plasmid loss in isolate 51 responsible for the
susceptible phenotype. AMX: amoxicillin, Sul: sulfonamide, St: streptomycin, Te: tetracycline. (B) Growth curves in Luria Bertani broth at 37uC of 8
isolates, showing impaired growth of isolates 45, 52 and 58. (C) Carbon source utilisation using Biolog GN2 plates that test 95 substrates. Only
substrates differentially used by the isolates are indicated. The substrates are as follows. a: Dextrin, b: Bromosuccinic Acid, c: Glucuronamide, d: L-
Alanine, e: L-Asparagine, f: L-Aspartic Acid, g: Glycyl-L-Aspartic Acid, h: L-Serine, i: D,L-a-Glycerol Phosphate. Substrates with a star correspond to
substrates whose metabolism is stimulated by an rpoS disruption [39]. Black and white squares indicate the use or the absence of use of the
substrate, respectively. (D) Non motile (52) and motile (54) isolates in 0.35% agar plates incubated for 48 hours at 37uC in humid atmosphere. (E)
Sensitivity to H2O2 measured by the survival in % at different times. The greatest differences were observed at 5 minutes. The colour code for the
isolates is as in (B). (F) Kaplan-Meier curves estimating the survival function of mice subcutaneously inoculated by 26108 colony forming units of the
different isolates. Only one curve of each statistically significant category is presented. Isolates range from the more to the less virulent as follow:
isolates 54 and 50 (group 4), isolates 42, 47 and 51 (group 3), isolates 52 and 58 (group 2) and isolate 45 (group 1).
doi:10.1371/journal.ppat.1001125.g004
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involve not just RpoS, but also additional stress-specific responses
(e.g. the heat shock or low pH responses) whose expression is
directly or indirectly affected by the RpoS level. For example the
acid stress resistance is influenced by numerous components
including AR2 system whose expression can be initiated with
either of two sigma factors RpoS and RpoD [43]. Similarly, DsrA,
a small RNA, influences multiple acid resistance genes of E. coli as
well as RpoS levels [44]. Therefore changing levels of DsrA, AR2
repressor H-NS and RpoS could give rise to non-linear
relationships in the SPANC balance trade-offs as illustrated in
Fig 8.
This simple model demonstrates that the SPANC balance is
sufficient to create diversity in RpoS expressions within an E. coli
population, and does not require any specific effect of the immune
system.
The intrinsic virulence of isolates from a single clone is
highly variable
Even if models predict that the mutants with variable levels of
RpoS may emerge in the absence of immune selective pressure, we
wanted to test the impact of RpoS phenotype on virulence. We
therefore investigated the intrinsic extraintestinal virulence of each
of the 8 representative isolates of patient 3, in a mouse model of
septicemia [27]. Statistically significant differences were obtained
between isolates, defining 4 groups (1 to 4), with the most virulent
killing 100% of the mice in less than 15 hours (group 4) and the least
virulent killing only 40% of the mice (group 1), the 2 other groups
being intermediate (Fig. 4F). These groups are significantly
correlated to growth properties; better growth gives greater
virulence (Fig. 6). In confirmation, competition experiments in
mice inoculated with a 1/1 ratio of isolate 58 (having an impaired
growth) and reduced mouse killing (group 2) and isolate 42 (having a
normal growth) and relatively high mouse killing (group 3) (Fig. 4F),
showed a survival curve identical to the one observed in mice
infected with isolate 42. Bacterial counts in the spleens of the killed
mice showed a culture consisting. 99% of the 42 isolate. Identical
results between these two strains were obtained after 24 h of in vitro
competition in Luria Bertani broth (data not shown).
Hence the RpoS-associated impaired growth is not beneficial in
the systemic phase of infection mimicked by the mouse model of
septicemia, and the polymorphism observed may be driven mostly
by the SPANC balance.
Table 2. Phenotypic characteristics of E. coli isolates showing an impaired growth.
Isolate ID
a
Growthb Biolog GN2
c
Motility
c
H2O2 sensitivity
c
Acid sensitivity
e
Lag
time (h)
Generation
time (h)
Biomass in stationary phase
(108 bacteria.ml21)
3-42 1.5 (0) 1.7 (0.03) 14.4 (0.2) 39 + + intermediate
3-45 1.5 (0) 2.4 (0.09) 13.9 (0.3) 39 + + intermediate
3-47 1.5 (0) 1.7 (0.06) 14.8 (0.3) 35 + 2 low
3-50 1.5 (0) 1.6 (0.05) 14.9 (0.4) 36 + 2 low
3-51 1.5 (0) 1.6 (0.07) 15 (0.4) 36 + 2 low
3-52 1.5 (0.2) 4.7 (0.36) 11.4 (1.4) 34 2 2 low
3-54 1.5 (0) 1.7 (0.09) 15.1 (0.5) 38 + + intermediate
3-58 2.0 (0.1) 4.3 (0.41) 12.2 (2.2) 32 2 2 low
5-4228 2.3 (0) 1.8 (0.04) 12.6 (0.1) 48 + + intermediate
5-4225 2.3 (0) 1.8 (0.04) 10.4 (0.4) 44 2 2 intermediate
11-4252 1.5 (0) 1.5 (0.01) 14.1 (0.1) NDd + 2 low
11-4250 1.8 (0) 2.0 (0.03) 13.3 (0.2) ND + + high
13-4432 2.2 (0) 1.8 (0.1) 13.7 (0) 40 + 2 intermediate
13-4433 2.6 (0) 2.3 (0.01) 12.9 (0.2) 35 2 + high
14-4231 1.9 (0) 1.6 (0.03) 13.9 (0.1) ND 2 + low
14-4245 2.6 (0) 2.0 (0.09) 11.5 (0.2) ND + 2 intermediate
15-P5-30 1.9 (0.1) 1.4 (0.07) 14.0 (0.2) 43 + + intermediate
15-P5-24 2.2 (0) 1.9 (0.11) 13.3 (0.2) 40 2 2 low
17-P5-40 1.9 (0) 1.7 (0.05) 13.7 (0) 37 ND + intermediate
17-P5-38 2.4 (0) 1.8 (0.04) 13.5 (0.1) 28 2 2 intermediate
17-P5-41 2.7 (0) 3.3 (0.56) 13.9 (0.1) 34 + 2 intermediate
19-486 2.3 (0.2) 1.3 (0.07) 14.4 (0.2) 45 + + low
19-474 2.4 (0) 1.6 (0.04) 13.2 (0.2) 43 2 2 low
aFirst number corresponds to the ID patient. The first isolate is the normal growth control.
bThe experiments were repeated 3 times. The data are presented as the mean +/2 standard deviation in brackets.
cIn all cases, comparisons are made between isolates of the same patient. For the Biolog GN2, the total number of used carbon sources is indicated. See Table S4 for the
complete list of carbon sources. For motility and H2O2 sensitivity, only two categories were considered: + corresponds to increased motility and H2O2 sensitivity as
compared to 2.
dND, not determined because of the absence of growth.
eSee material and methods for the categorization.
doi:10.1371/journal.ppat.1001125.t002
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Discussion
Infections of a single patient by several distinct isolates is
common in extraintestinal E. coli infections and result
from different phenomena
To our knowledge, this work is the first one to investigate
thoroughly, using molecular tools, numerous isolates from single
patients in a large series of deep and severe extraintestinal E. coli
infections. E. coli responsible for extraintestinal infections can be
considered as opportunistic pathogens with the commensal
reservoir being the intestinal tract [20,21]. We observed an
unexpectedly high level of within patient bacterial polymorphism
as 11 of the 19 (58%) patients were infected by genotypically and/
or phenotypically diverse bacteria. This diversity, as previously
reported in other species [2,3,4,5,6,7,8,9,10], is of two types.
Patients are infected either by several distinct E. coli clones or by a
single clone with micro-heterogeneity. Both types of diversity can
be observed in some patients. Patients with distinct E. coli clones
were clearly infected from the intestinal commensal niche by
different clones. Of note, these multiple infections are physically
closely related to the commensal reservoir (Table 1). For the
patients infected by a single clone that presents some micro-
heterogeneity, two scenarios, not mutually exclusive, can be
envisaged: the observed diversity could have pre-existed to the
infection process in which a subset of the digestive tract diversity
would have been sampled or the diversity could have emerged in
the course of the infection that was initiated by a single isolate or
few identical isolates. Several arguments favour the second
hypothesis. First, in the cases with micro-heterogeneity, the
infected organs were more diverse (kidney in 3 cases, digestive
apparatus in 2 cases, pleural fluid and cerebrospinal fluid in one
case each, associated in 2 cases to bacteremias) than in the patients
infected by distinct clones, suggesting a less evident route for
digestive tract bacteria to the infection zone. Second, we have
studied the level of phenotypic polymorphism in E. coli isolates
from stools of healthy subjects harbouring unique clones and
found a significantly lower level of polymorphism in antibiotic
resistance and growth patterns than in infections. Third, the tree
reconstructed from the phenotypic and proteomic data (Fig. 7) of
the 8 representative isolates of the patient 3 appears as a star like
phylogeny and indicates a rapid diversification from a unique
ancestor. Fourth, such scenario of diversification during the
infectious process has been experimentally confirmed in a rat
model of S. epidermidis foreign body-associated infection [7].
Similarly, genomic changes were observed in H. pylori during
gastric experimental infection in rhesus monkey [45]. Lastly, it has
Figure 5. Level of RpoS in 8 representative E. coli isolates of patient 3. The level of RpoS was assessed by rdar morphotypes (A), staining
glycogen with iodine solution (B) and RpoS immunoblot (C). RpoS amount is expressed as the ratio of the RpoS band to a constant cross-reactive
band. The negative control (E. coli MG1655 DrpoS strain) is on the right part of the figure. Experiments in B and C were repeated 2 times, given values
are the mean of the two experiments.
doi:10.1371/journal.ppat.1001125.g005
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been demonstrated in immunocompetent rodent models that
bacteremias resulting from experimental colonisations are the
products of very few bacteria [46,47,48], or even a single one [49].
The molecular bases of the within-clone phenotypic
diversity
Some of the observed phenotypic diversity (antibiotic resistance,
iron capture system) was easily explained by the loss of plasmid
borne determinants. It has been shown that in stressful conditions,
the induction of the SOS system mobilises transposons [50],
integrons [51], as well as virulence genes [52]. The remaining
phenotypic diversity was mainly RpoS related but we did not
identified mutation in the rpoS gene or in the more than 20 diverse
regulators that have been shown to influence RpoS levels [17].
Instead, we observed few mutations in metabolic and membrane
related genes (Table 4). The convergence in ompA, the mutation in
the rbs operon that has been shown to be under selection in
experimental evolution system [42] and the presence of mutators
(Table S3) are strong arguments for the fact that these mutations
have been selected. Of note, ompA is among the 23 genes that show
evidence of positive selection in E. coli [53]. The genomic
mutations we identified suggest that SPANC balance can be
affected by an even larger set of pleiotropic mutations, many of
them yet unknown. For example, the overproduction of the
EmrAB-TolC multi-drug efflux transport system in the mprA
mutant, and the nutrient starvation in the ompA mutants could
explain the altered growth and the RpoS response in isolates 45
and 58 (Table 4). In these cases, the RpoS phenotype would be
secondary to the phenotype generated by the mutations. A
limitation of our approach is that, (i) we could have missed IS
based chromosomal reorganisations and gene amplification(s) and
(ii) unlike in experimental evolution experiments, we do not have
the ancestor clone that could allow us to perform reconstruction
experiments with the mutated alleles and competitions [54],
confirming the direct implications of the mutations in the observed
phenotypes.
The evolutionary forces that drive the single clone
diversity
A wide continuum of growth rate, stress resistance, outer
membrane permeability, rdar morphotype and virulence proper-
ties were observed within isolates of single clones, directly linked to
the SPANC trade-off and associated with distinct levels of the
sigma factor RpoS in isolates (Figs 3, 4, 5, 6 and S1). rpoS
mutations have been reported in E. coli laboratory and natural
isolates as they are probably selected for in nutrient-limited
environments [16]. Indeed, an important variation in the level of
RpoS was observed in an E. coli clonal population grown in
constant environment in a chemostat. This population radiated in
more than five phenotypic clusters, two including rpoS mutant
isolates [15]. In some other experimental evolution systems,
duplications of rpoS have been reported [37], suggesting that
Figure 6. Statistically significant links between phenotypes and the 27 differentially expressed proteins of the 8 representative E.
coli isolates of patient 3. The links depicted by a line, in green when positive (phenotypes and/or amounts of protein increase together) or in red
when negative (a phenotype or an amount of protein increases when the other increases). Lighter is the line, more significant is the link. Only one
protein (putative outer membrane protein) is not linked. Note that the links presented here are coherent with those of the phenotypes from the data
set corresponding to 23 isolates originating from 8 patients (Fig. S1).
doi:10.1371/journal.ppat.1001125.g006
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higher or lower level could be achieved depending on the exact
setting of the experiment. Our data in infected patients hence
parallel these observations made in experimental evolution systems
in the absence of immune selective pressure, and were explained
by the simple mathematical model. This fully supports the idea
that the SPANC balance is sufficient to promote a strong
phenotypic diversification at intermediate stress levels (Fig. 8). Of
course there are numerous other mechanisms [55] that could
generate the diversity patterns observed in this study, such as
environmental heterogeneities or immune system driven negative-
frequency dependence. But the model provided here is a test of an
alternative coexistence mechanism. The model assumptions have
been deliberately kept simple in order to illustrate a minimal set of
conditions under which the SPANC balance trade-off could lead
to coexistence of E. coli genotypes with differing levels of RpoS. In
particular the SPANC balance trade-off is defined through a single
evolving phenotype, namely the RpoS expression and we conclude
that complex but nonetheless realistic shapes of the trade-off are
required for the diversity to be maintained. However, increasing
the number of traits through which the trade-off exists will reduce
the complexity of the shapes required to observe diversity [56].
The lack of mutations in rpoS itself that we observed suggests
RpoS loss is detrimental under host infection conditions. Indeed,
the role of RpoS in vivo is not clear as rpoS mutants are selected
within the gut in commensal E. coli [57] but are avirulent in a
mouse model of septicemia with Salmonella [58]. To test further if
RpoS polymorphism is a virulence-linked effect, we tested the
various isolates of patient 3 in a mouse model of infection. Yet we
could not identify a virulence-linked benefit of high level of RpoS,
as lower virulence was associated to lower growth rate (Fig. 4F
and 6).
Another source of variation supported by theoretical and
experimental approach is the one concerning iron uptake. Iron is
essential for the growth of bacteria and they produce and release
iron-chelating small molecules known as siderophores to scavenge
iron from their hosts. Siderophore production is considered as an
altruistic trait that is costly for the individual but provides a group
benefit because other individuals can take up the siderophore-iron
complex [18]. P. aeruginosa mutants that do not produce side-
rophore (cheaters) have been seen to evolve both in vitro [59] and in
the lungs of cystic fibrosis patients [60]. Similarly, we observed
within clone variability due to the coexistence in a same sample of
isolates with different siderophore encoding gene content due to
plasmid loss (Table S1). A frequent observed polymorphism in the
monoclonal infection cases is also the presence or absence of
penicillinase production (Fig. 3A and Table S2), due to a bla
plasmid borne gene. As in the case of siderophore production,
penicillinase production could be seen as an altruistic trait in the
presence of antibiotics. The effect could also be reinforced by the
fact that plasmids may carry other secreted (altruistic) proteins
[61].
One emerging question related to the presence of some strong
diversity in phenotypes as important as growth, resistance to stress
or antibiotic resistance, is what are the consequences in term of the
infection outcome. In other words, how such a polymorphism
affects the virulence of the bacterial population. The emergence of
cheaters lacking siderophore or eventually antibiotic resistance
genes (and the other genes carried on the plasmid) clearly
illustrates that selection may not always favour the most virulent
genotypes, and that within-population selection may on the
opposite select for genotypes that reduce the infectious power of
the population as a whole [62]. Along the same line, our
mathematical modelling suggests that the SPANC trade-off allows
the emergence of some variable bacteria independently of the host
immune system, and our animal model of infection revealed that
the most stress resistant ones are not the more virulent. Yet, the
existence of some strong variability along the SPANC balance may
sometimes be beneficial as many different strategies are present
within the population and some may be more efficient than other
in the different stages of the infection.
Concluding remarks
Our results suggest that experimental evolution and the
evolution of diversity in the course of an infection may have
many parallels. Whether or not this diversity promotes increased
virulence remains an open question, that will require further work
to link the observed mutations to the various phenotypes and to
some potential virulence linked effects.
Table 3. List of the 27 proteins differentially expressed
between the 8 representative E. coli isolates of patient 3.
Protein Genea
Fold
changeb ANOVA (p)
Central metabolism
Ribokinase rbsK 8.26 9.25E-08
Fructose biphosphate aldolase class I fbaB* 4.91 1,46 E-3
Pyruvate dehydrogenase poxB* 24.2 8,56E-04
Acetyl-coA synthetase acs* 2.90 7,58E-04
Hydrogenase 1 large subunit hyaB* 20 3.48E-04
NAD(P)H:quinone oxidoreductase wrbA* 8.24 5.78E-04
Transaldolase A talA* 6.15 1,83E-04
2-oxoglutarate dehydrogenase subunit sucA* 19.7 2.97E-05
Phosphomannomutase cpsG 4.40 6.20E-04
Phosphoglucosamine mutase glmM 1.76 4.85E-05
Periplasmic L-asparaginase II ansB 5.83 9.31E-06
Threonine/Serine deaminase tdcB 3.19 2.29E-05
DNA-binding ATP-dependent protease lon 8.11 7.30E-10
DNA gyrase, subunit B gyrB 9 2.68E-06
tRNA nucleotidyl transferase cca 2.13 8.27E-04
Isoleucyl-tRNA synthetase ileS 4.25 4.21E-05
Membrane
D-ribose transporter subunit rbsA 20.0 4.11E-06
D-ribose transporter subunit rbsB* 14.3 6.63E-07
Preprotein translocase subunit, ATPase secA 6.79 9.03E-04
Transport channel tolC 2.13 3.17E-04
Outer membrane protein A ompA* 9.03 8.73E-05
Outer membrane protein C ompC* 4.65 1.13E-05
Maltose outer membrane porin lamB* 3.4 8.57E-04
Outer membrane porin; DLP12 prophage nmpC* 1.87 7.90E-04
Putative outer membrane protein NDc 6.78 8.10E-05
Stress
Glutamate decarboxylase A, PLP-
dependent
gadA* 4.37 4.98E-05
Catalase HPII katE* 3.50 8.77E-04
aGenes indicated by a star were shown to be regulated by RpoS
[83,84,85,86,87].
bCalculated between minimum and maximum normalized spot volumes of the
8 isolates.
cND, not determined.
doi:10.1371/journal.ppat.1001125.t003
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Figure 7. Neighbour joining distance tree based on the phenotypic and proteomic data indicating the relationships between the 8
representative E. coli isolates of patient 3 with the identified mutations. Bootstrap values in percentages are calculated from 10,000
replicates. The boxed isolates correspond to the isolates fully sequenced. The isolate with a star (51) is a mutator isolate. The identified mutations
(Table 4) as well as the plasmid loss are indicated in boxes at each isolate.
doi:10.1371/journal.ppat.1001125.g007
Table 4. Mutations identified by whole genome sequencing on 4 E. coli isolates of patient 3.
Isolate Localisation of the mutation Mutationa Function
Protein
variationb
42 yagX
ybdL
tktA
G 384,100 A (Phe 118 Phe)
T 676,307 C (Met 240 Thr)
T 3,376,675 C (Ile 21 Val)
Aromatic compound dioxygenase
Methionine aminotransferase
Transketolase 1, thiamin-binding
45 rbsR
Intrinsic transcription terminator
of ompA
A 4,440,121 C (Thr 288 Pro)
C 1,062,754 A
DNA-binding transcriptional repressor of ribose metabolism
Outer membrane protein
RbsA, B, K +
OmpA 2
50 Between gadX and gadW Insertion of an IS1 element at 4,103,497 Transcription regulators of gadA GadA +
58 Ribosome binding site of mprA
Between gadX and gadW
ompA
T 3,091,307 C
Insertion of an IS1 element at 4,103,497
5 bp deletion between 1,063,473–1,063,479
DNA-binding transcriptional repressor of multidrug efflux
pump EmrAB-TolC
Transcription regulators of gadA
Outer membrane protein
TolC +
GadA +
OmpA 2
aThe numbers between nucleotides correspond to the localisation of the mutation in the CFT073 genome according to MaGe [79] whereas the number between the
amino acids corresponds to the amino acid numbering of the protein, when relevant.
bThe variation is given for the protein itself or for proteins directly regulated by the encoded protein. Plus and minus signs indicate increased or decreased level of
protein, respectively. Data are from the proteomic analysis (Table 3).
doi:10.1371/journal.ppat.1001125.t004
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Whatever the mechanisms leading to diversity (infections by
several distinct isolates or diversification during the infectious
process), our results have strong medical implications in term of
antibiotic therapies. Indeed, although an individual can harbour
several independent commensal clones [63], the classical
medical assumption about extraintestinal E. coli infections is
that they are strictly monoclonal. This is typified by the
antimicrobial susceptibility testing performed on few (2 to 5)
colonies obtained from the pathological sample to establish
antibiotic treatment [64,65]. This may fail to detect the
presence of other, more resistant isolates, and lead to
therapeutic failure [66]. Our work showing an impressive level
Figure 8. Model of the distinct levels of RpoS. (d) Long-term population structure supporting two genotypes with distinct levels of RpoS,
requires the benefit of stress protection and maximal rate of resource uptake to have the form illustrated in (a) and (b) respectively. (e) Long-term
population structure supporting three genotypes with distinct levels of RpoS, requires the benefit of stress protection and maximal rate of resource
uptake to have the form illustrated in (c) and (b) respectively. Here e= 0.32561028, S0 = 1.1610
9 picomoles of sugar, D= 0.0017 per minute,
k= 46106 picomoles of sugar and r= 237 cells per picomole of sugar. The maximal uptake rate f(x) is measured in picomoles of sugar per cell per
minute.
doi:10.1371/journal.ppat.1001125.g008
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of antibiotic resistance phenotype variability within the isolates
of a single patient argues for the utilisation of a mix of numerous
isolates to perform the antibiogram, or, alternatively for the
realisation of simplified antibiograms with essential molecules
on numerous isolates in addition to the classical antibiogram on
a single isolate.
Materials and Methods
Bacterial strains
A total of 226 E. coli isolates responsible for severe infections in
19 epidemiologically unrelated adult patients from 3 university
hospitals in France [Brest, Paris suburbs (Colombes and Clichy)],
were studied (Table 1). To avoid contamination, only deep and
closed visceral infections were selected (pyelonephritis, meningi-
tis, pleurisy, cholecystitis, intra-abdominal deep abscess, ascitic
fluid, peritoneal fluid and placental infections and bacteraemia).
For 5 patients (1, 2, 3, 4 and 19), two samples were analysed
(blood plus another site of infection), whereas only one sample
was studied for the remaining patients. Except for urinary tract
infection, samples were obtained during surgery or through
sterile punctures. In all these infections, E. coli alone was
recovered. For each sample, 5 to 20 colonies isolated on blood
agar or CLED (cystine lactose electrolyte deficient) plates were
randomly selected and stored with glycerol at 280uC before use.
In addition, 150 commensal isolates belonging to 15 subjects (10
isolates per subject) matched for geographic origin (Brest, Paris
suburbs) and sex with the patients [63] were studied as controls.
Each subject exhibits identical isolates based on the phylogenetic
group/subgroup and the virulence gene content, but the isolates
of the different subjects belong to various phylogenetic group/
sub groups. Isolates were stored with glycerol at 280uC before
use.
Human ethics statement
All the sampling procedures of the infected patients were
performed in the course of the clinical diagnosis. No additional
procedure was performed in the patients for the present study. The
study was approved by the institutional ethics committee (Comite´
de Protection des Personnes, Hoˆpital Saint-Louis, Paris; #2004-
06). For the healthy subjects, the study was approved by the ethics
committee of INSERM (IRB0000388, FWA00005831), with the
opinion #01-014. In both studies, the participants were informed
of their role in the study and written informed consent was
provided by study participants.
PCR phylotyping and virulence factor pattern
All pathogenic isolates were assigned to the 7 E. coli
phylogenetic group and subgroups using triplex PCR based on
the presence or absence of three DNA fragments (chuA, yjaA and
TSPE4.C2) [63]. The presence of 20 extraintestinal virulence
factors (VFs) (neuC, sfa, iroN, iucC, iutA, iha, papC, papG, hlyC, cnf1,
hra, sat, ire, usp, ompT, ibeA, malX, fyuA, irp2 and traT) was tested by
PCR on all isolates, as previously described [31].
Enterobacterial Repetitive Intergenic Consensus
(ERIC)-PCR
ERIC-PCR was performed on all pathogenic isolates, as
previously described [67] using separately three different primers
to increase the discriminatory power of the technique: ERIC1 (59-
GTGAATCCCCAGGAGCTTACAT-39), ERIC1R (59-ATG-
TAAGCTCCTGGGGATTCAC-39) and ERIC2 (59-AAGTAA-
GTGACTGGGGTGAGCG-39).
Pulsed Field Gel Electrophoresis (PFGE) and analysis of
strain relatedness
One hundred and ten pathogenic isolates from 11 patients (3, 5,
8, 11, 12, 13, 14, 15, 16, 17 and 19) in whom strain heterogeneity
was observed in the antibiotypes and/or phylogenetic group/
subgroups and/or virulence gene patterns and/or ERIC patterns,
were further studied by PFGE. As previously described [68],
PFGE was performed after digestion of chromosomal DNA with
XbaI, which gave a convenient number of fragments. These
fragments were separated in 0.5 X TBE buffer, pH 8.0, at 14uC
and 6 V/cm with pulse times of 5–50 s for 21 h. DNA patterns
obtained were analysed with Gel Compar software (Applied
Maths, Kortrijk, Belgium). A similarity matrix was created by
using the band-based Dice similarity coefficient, and Ward’s
algorithm was used to cluster the strains.
Multi Locus Sequence Typing (MLST)
MLST analysis based on the concatenated sequences of 6
essential genes (trpA, trpB, pabB, putP, icd and polB) [26] was
performed in some cases to determine the relatedness between the
isolates. In addition, the sequence of gnd, one of the most variable
gene in E. coli due to a high level of recombination [30], was
occasionally performed to further discriminate isolates.
Antibiotic susceptibility
Antimicrobial susceptibilities were determined on all the
pathogenic and commensal isolates by the method of disc
diffusion, according to the guidelines of European Committee
for Antimicrobial Susceptibility Testing (www.eucast.org). The
tested resistance markers were as follow: amoxicillin (AMX),
amoxicillin-clavulanate, ticarcillin (TIC), piperacillin (PIP), piper-
acillin-tazobactam, imipenem, cefalotin (Cf), cefamandole, cefur-
oxime, cefoxitin, cefotaxime, ceftazidime, cefepime, aztreonam,
mecillinam, streptomycin (St), kanamycin (Ka), gentamicin,
tobramycin, netilmicin, amikacin, tetracycline (Te), minocycline
(Mn), nalidixic acid (Na), pefloxacin, ciprofloxacin, chloramphen-
icol (Ch), fosfomycin, sulfonamides (Sul), trimethoprim (TMP).
MICs were determined by the E-test method (AB Biodisk, Solna,
Sweden) as recommended by the manufacturer. The production of
penicillinase (Pase) was deduced from the resistance profile
(resistance to amoxicillin, ticarcillin, piperacillin and intermediate
susceptibility to amoxicillin-clavulanate, piperacillin-tazobactam
and cefalotin) and confirmed by the detection of blaTEM by specific
PCR amplification as previously described [69].
Outer membrane permeability
The isolates of patient 17 were electroporated with the plasmid
pBR322 to introduce high levels of b-lactamase into all strains.
Outer membrane permeability was measured by comparing b-
lactamase activity in whole cells (with intact outer membrane) to
that in disrupted cells with no barrier, using the permeable
colorimetric substrate nitrocefin [70]. Bacterial strains were
grown to exponential phase at 37uC in Luria-Bertani (LB) broth
without salt containing either 100 mg/ml ampicillin or 15 mg/ml
tetracycline. The optical density of the culture was measured and
two 100 ml samples were taken. One aliquot (whole cells) was
washed once, resuspended in the same volume of 0.16M9 and
the second aliquot was centrifuged and resuspended in 30%
sucrose, 33 mM Tris. 5 ml 2 mg/ml lysozyme and 5 ml 0.2M
EDTA and the mixture placed on ice for 15 min. Lysed bacteria
were centrifuged for 5 min at 4uC, the pellet discarded and 3 ml
1M MgCl2 added to the supernatant. The broken cells and whole
cells were assayed in 96 well micro titre plates with each well
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containing 160 ml 0.16M9, 20 ml 50 mg/ml nitrocefin and 20 ml
of the sample. The 96 well plate reader was configured for
kinetics at 492nm for 20 min with readings taken every 2 min.
The activity of the broken cells was very similar and quadruple
assays were used to generate the values plotted in Fig. 3C. The
activity is presented as the rate of optical density change/min/cell
in the assay.
Bacterial growth
Cells grown overnight in LB broth were washed and transferred
into a fresh LB medium at a dilution of 1:250. The growth rates
were then measured for all the pathogenic and commensal isolates
at 37uC by monitoring the optical density at 600 nm (Tecan
microplate reader) in LB medium. Experiments were repeated 3
times.
Carbon source utilisation
Biolog GN2 (Biolog, Inc., Hayward, CA) microplates were used
to detect carbon utilization of 95 substrates in isolates of patients
where a micro-heterogeneity was observed. Utilization of various
C sources is coupled to reduction of a tetrazolium dye and
production of purple colour [38]. Each strain was grown in LB
medium, washed and resuspended to an optical density at 600 nm
of 0.01 in mineral medium. Mineral medium was prepared as
described elsewhere [38]. Plates were incubated at 37uC and
colour changes were measured by optical density measurement
(Tecan microplate reader) at a wavelength of 600 nm. The cut off
point between negative results and positive results was an optical
density of 0.2. Experiments were repeated 2 times. For the
statistical analysis, the data considered were, for each isolate, the
number of used substrates.
Hydrogen peroxide sensitivity
Bacterial isolates from patients showing differences in the
growth kinetic were grown overnight in LB, washed, and
resuspended in 0.9% NaCl to a concentration of about 1.108 cells
ml-1. H2O2 was added to a final concentration of 50 mM.
Aliquots of bacteria were removed at timed intervals, and numbers
of viable cells were determined on LB plates. For the statistical
analysis, only two categories were considered (resistant or
sensitive). To delimit in categories the 8 isolates of patient 3, area
between curves was used as a distance in order to compare curves.
A k-means approach (two seeds, i.e. two clusters) on such distance
matrix allows an automatic separation of clusters. As a control for
the choice of the number of clusters, we represented these curves
(according to the described distances) as points in a two
dimensional Euclidean space thanks to an effective non-linear
multidimensional algorithm named Data Driven High Dimen-
sional Scaling (DD-HDS) [71]. Two clusters (categories) can be
considered as fair.
Acid sensitivity
To assess the acid sensitivity phenotype of the isolates from
patients showing differences in the growth kinetic, we used a
protocol previously described [72] with some minor modifications.
An inoculum containing about 108 cells from an overnight LB
culture was introduced into LB acidified with HCl (35%) to
pH 2.5. After two hours of exposure to pH 2.5, surviving cells
were counted and the percentage of survivor was calculated.
Strains which exhibited greater than 10% survival were designed
acid resistant (low sensitivity), strains with 0.1% to 10% were
designed intermediate in acid sensitivity, and those with less than
0.1% survival were considered acid sensitive (high sensitivity).
Motility
Cells of isolates from patients showing differences in the growth
kinetic were grown overnight in LB, washed, and resuspended in
minimum media (PO4 acetate) to a concentration of 1.10
2 cells
ml21. About 10 cells were grown in standard Petri dishes
containing 20 ml minimum (PO4 acetate) media with 10mM
glucose, solidified with 0.35% agar. Swim plates were incubated
48 hours at 37uC in humid atmosphere. Experiments were
repeated 2 times. For the statistical analysis, only two categories
were considered (motile or non motile).
Rdar morphotype
Cells of isolates from patients showing differences in the growth
kinetic were grown on LB agar plates without NaCl (LB0) at 28uC.
We determined colony morphology and colour using LB0 agar
supplemented with Congo red (40mg.ml-1) and Coomassie brilliant
blue (20 mg.ml-1), as described previously [41].
Iodine staining
Level of RpoS was obtained in 8 selected isolates of patient 3
by staining colonies on LB agar plates. Plates were incubated for
24 hours at 37uC and then left at 4uC for 20 hours before being
flooded with Lugol (I2 concentration = 10g.L
21). Iodine
staining is dependent on glycogen, whose synthesis is affected
by RpoS [73]. Dark-brown colonies correspond to a high level
of RpoS. A control corresponding to E. coli MG1655 DrpoS
strain was used. Experiments were repeated 2 times. For the
statistical analysis, a scale from 1 to 5 depending on the darkness
was used.
RpoS immunoblot
Cells were harvested in stationary phase after 18 hours of
culture in LB at 37uC, and proteins were extracted in SDS 1% at
100uC for 10 min. Protein concentration was measured by the
method of Bradford (DC protein assay, Bio-Rad). SDS-PAGE
was carried out in 10% polyacrylamide minigels (Mini Protean
II; Bio-Rad). 10 mg of total proteins was loaded into each lane.
The proteins were transferred to Amersham Hybond-P mem-
brane (GE Healthcare) with a Mini TransBlot cell (Bio-Rad) in
transfer buffer (25 mM Tris [pH 8.2], 192 mM glycine, 20%
[vol/vol] ethanol). Western blot analysis was performed by
serially incubating the membrane with polyclonal rabbit
antibodies against the sS protein [74] overnight (1:150000),
and Amersham ECL anti-rabbit IgG (GE Healthcare), for one
hour (1/20000). The RpoS protein was visualized using the
Amersham ECL Plus Western Blotting Detection System (GE
Healthcare). Quantifications were performed using a Phosphor-
Imager (Molecular Dynamics). Data correspond to the ratio of
the RpoS signal to a constant cross-reactive band. A control
corresponding to E. coli MG1655 DrpoS strain was used.
Experiments were repeated 2 times, values are the mean of the
two experiments.
rpoS gene and promoter sequencing
DNA was prepared from 8 selected isolates of patient 3 using
the Wizard Genomic DNA purification Kit (Promega). Two PCR
products (product 1: primer forward ACAAGGGGAAATCCG-
TAAACC; primer reverse AGGATTTCGCGCAAACG, length:
1059 bp, and product 2: primer forward CCGTACTAT-
TCGTTTCGGCCGA; primer reverse GAGACTGGCCTT-
TCTGACAG, length: 536 bp) were used to obtain the sequence
of the rpoS gene and its promoter. Sequencing of PCR products
was performed on both strands by classical Sanger technology.
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Mouse extraintestinal virulence assay
A mouse model of systemic infection was used to assess the
intrinsic virulence of 8 selected isolates of patient 3. For each
isolate, 10 outbred female Swiss OF1 mice (3–4 weeks old, 14–
18 g) received a 200 mL subcutaneous abdominal injection of 109
CFU/mL of stationary-phase bacteria. Mortality was monitored
for 7 days [27]. Kaplan-Meier curves were drawn from the data.
Isolates were classified in 4 significantly different virulence groups,
from group 1 for the less virulent to group 4 for the more virulent
group (p of log rank test , 0.05). This classification was used for
the statistical analysis. Competition experiments were performed
by inoculating 10 mice by a 1/1 ratio of strains 42 and 58. Cells
were numbered in the spleens of animals after grinding and sprawl
on LB agar plates. Distinction between isolates 42 and 58 was
done using the iodine staining assay that stains glycogen (RpoS
regulates positively glgA, the glycogen synthase gene and colonies
from isolate 58 were darker than colonies from isolate 42).
Animal ethics statement
Animal experiments were performed in compliance with the
recommendations of the French Ministry of Agriculture and
approved by the French Veterinary Services (accreditation A 75-
18-05).
Mutation frequency
Mutation frequencies of the isolates from 8 patients (91 isolates)
showing a micro-heterogeneity were estimated by monitoring their
capacity to generate mutation conferring resistance to rifampin in
at least three independent cultures for each isolate, as described
previously [33].
Bidimensional electrophoresis (2-DE) and mass
spectrometry analysis
For each of the 8 representative isolates of patient 3, three
independent protein extractions followed by 2-DE analysis were
realised. Cells were harvested exactly at the same time at the
beginning of stationary phase in LB and, after centrifugation
washed three times in physiological serum. Proteins were extracted
from cells by TCA-acetone precipitation according to [75],
solubilized in R2D2 buffer [76] and quantified using the PlusOne
2-D Quant kit (Amersham Biosciences, Arlington Heights, IL).
Isoelectrofocusing was carried out using 24-cm long, pH 4–7
Immobiline DryStrips (Amersham Biosciences) rehydrated in
R2D2 solubilization buffer to which 300mg of protein extract
was added. Full focusing was achieved after application of
84,000 V/hr at 20uC in a Protean IEF Cell (Bio Rad, Hercules,
CA). Strips were equilibrated according to [77]. Second dimension
electrophoresis was performed at 14uC (16 hr, 30 mA/gel) on a
24624-cm gel (11% acrylamide, 2.9% of PDA crosslinker) in a
Protean Plus Dodeca cell (Bio-Rad). Gels were stained by colloidal
Coomassie blue and scanned using the PowerLook III scanner
(Umax) and LabScan software (Amersham Biosciences). 2-DE gel
image analysis was performed using Progenesis SameSpots
(Nonlinear Dynamics). After optical density calibration, spot
volumes were normalized according to total spot volume in each
gel. Relative quantification of the detected spots was made in
percentage of total spot volume (integrating optical density and
spot area) for each gel, which allowed normalization of the values.
Spots showing a significant variation between isolates (ANOVA
test: p-value , 0.001) were excised with an EXQuest Spot Cutter
(BioRad) and digested using a standard trypsin protocol as
described by [78]. After digestion the supernatants were harvested
and frozen at 220uC. Mass spectrometry identification of proteins
was performed using a MALDI-TOF mass spectrometer Voyager
DE super DTR system (Applied Biosystems, Foster City, CA,
USA) equipped with a nitrogen laser emitting at 337 nm. Spectra
were obtained in the mass range between 1000 and 2500 Da and
were calibrated using internal calibration with autolytic trypsin
fragments. Proteins were identified using the protein sequence
database search program MS-FIT (http://prospector.ucsf.edu/
prospector/4.0.7/html/msfit.htm) and the database MaGe (Geno-
scope, Evry France) [79]. Database search results were only
accepted if the score reported by MS-FIT was higher than 1e4.
Whole genome sequencing
Four representative of the 8 isolates of patient 3 were fully
sequenced. Genomic DNA was prepared using the Wizard
genomic DNA purification kit (Promega) and sequenced with
Solexa (Illumina) technology (Genoscope, Evry, France). The fastq
files were then analysed though the Sanger pipeline SSAH2 [80],
using CFT073 genome [79] as a reference genome. Preliminary
analysis showed that it was the closest E. coli sequenced genome.
We first confirmed this observation as the isolates are less than
0.1% diverged from CFT073 and share more than 95% of their
genome with CFT073. For each isolate, using the mapping of
reads on the reference genome, we could identify positions at
which the sequence differed from this reference sequence. At all
these sites, the number of reads supporting each of the four bases
was recorded in all the isolates. For each site, an exact Fisher test
was then performed among all pairs of isolates to detect any
difference in the distribution of the counts supporting each base.
Two kinds of significant deviation occurred. The ones with the
highest p-values were due to change of the base presenting the
highest counts between at least two isolates. These were all
confirmed to be mutations through targeted sequencing. The
other significant differences in distribution were due to change in
the ratio of frequency between the dominant and the second most
encountered base at the site. It only occurred in high coverage
regions and the dominant base remained the same. None of the
positions having such a profile we tested presented a different base
across lines. As we do not have the ancestral genome, we used
another approach in which instead of using the CFT073 genome,
we used a concatenation of contigs resulting from a de novo
assembly performed with Velvet software [81]. The same
mutations events were detected. Through the SSAHA2 package
we also identified small indels (,3bp long) compared to CFT073
genome, but none of them appeared to be specific to a subset of
strains, they were all shared by all strains.
Finally we wanted to detect IS transpositions. For that purpose,
we used the contigs assembled by Velvet software and looked for
IS tails in the border of the produced contigs. A library of E. coli IS
was recovered from ISFinder library (http://www-is.biotoul.fr/is.
html). All IS tails were blasted against the assembled contigs.
When a significant match was found, the 100 base pairs flanking
the targeted sequence in the contig were blasted against the
genome of CFT073. This provided a position of IS insertion
element in the genome. A few IS insertions were identified as
potentially different among the lines. To further comfort the
specificity of IS elements integration, in all strains, we looked for
the reads overhanging the suspected site of integration and see if
any reads were mosaic (having one part of the chromosome and
one part of the IS element border). After such a control a single site
appeared as an IS integration specific to some strains. It was
confirmed by targeted PCR analysis.
As deletion or other genomic rearrangement should also result
in mosaic reads (matching two parts of the genome), we used the
previous approach to scan all possible positions in the genome that
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were enriched in such mosaic reads in a specific subset of strains.
In addition to the previous IS element, we found a 5 bp deletion in
ompA uniquely in isolate 58 which was confirmed by targeted
sequencing.
While with these different approaches we have scanned close to
90% of the genome for punctual mutations, small insertion or
deletions, or IS integration, our approach is much more limited in
repeated regions the genome (although the use of de novo assembled
contigs suggest that in low copy regions no change were observed).
Moreover our approaches, based on the use technology, fail to
detect any IS based chromosomal reorganisation such as inversion
and gene amplification.
All mutations detected by whole genome sequencing (Solexa)
were verified by targeted sequencing using Sanger technology on
PCR products or by PCR and agarose gel electrophoresis (for the
IS detection) and searched on the other isolates of patient 3. The
PCR primers were as follow: mprA, forward CATTATCATCC-
CAACACTGC, reverse ACGCCATAAACAACGTCTCG; rbsR,
forward AATTTAACGGCGGGTTTGAC, reverse TTCAG-
CAGCAATGTTCATGC; ompA, forward ATCGTCTGGC-
AACGTCTGGC, reverse GACAAAATCTCCGCACGTGG;
yagX, forward ACTGGTTGTTATAGACGCCG, reverse CG-
TCCCGCTCTATATTCATC; ybdL, forward AACTGTC-
TGGCAGCAGACTG, reverse TCACCAGAATATCGCG-
CTTC; tktA, forward GGCTGTAGATCAGCATGGAG, reverse
GCAACATGCGAGCATGATCC; IS between gadA and gadW,
forward GCCAGACTGTTTCTGTGTGC, reverse CACGG-
GAAACTTTGTGCTCT; deletion in ompA, forward GGGT-
TACCCAATCACTGACG, reverse CAGCGAAGACCGGA-
GAAAC.
Statistical analysis
In order to determinate if a link between various phenotypes
(including RpoS level and 27 protein levels obtained by 2-DE
analysis) exists we used a non-parametric test in the line of the
Spearman’s rank correlation test. There is no reason to a priori
suspect that links between phenotypes are necessary linear. Values
have been sorted (equal ranks are given for equal values, as usual in
case of nonparametric analysis). However, according to the special
characteristics of the dataset, the classical Pearson’s rank correlation
test cannot be applied here. Indeed, because the obtained values for
each patient are not comparable, a unique sorting of data cannot be
reached. We thus sort values for each patient. For a couple of
phenotypes, the sum of absolute differences between the whole
resulting ranks is related to the possible link between phenotypes
(the strongest is the link, the lowest is the sum). A permutation test
gives access to a p-value: ranks are sorted (by patient) in order to
evaluate the distribution of such ranks in case of independence
between phenotypes (10,000 permutations in our implementation).
A similar analysis while ranks are reversed for one phenotype allows
accounting of negative links between phenotypes. For each couple
of phenotypes, we are thus able to evaluate the probability that a
link is existing. Links detected as significant (at the 5% level) are
drawn in Figs 6 and S1.
A distance tree of the 8 isolates of patient 3 has been constructed
from the phenotype and proteomic data. Because measures of
variables cannot be compared, we have rather considered ranks
(just as it has been done for the statistical analysis). The tree is
performed by neighbour-joining from Euclidean distances on
ranks.
Mathematical modelling
The evolutionary model tracking the rate of change of different
phenotypes within the E. coli population can be schematically
represented as in Fig. S4 and mathematically written as:
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For simplicity we consider a homogeneous environment contain-
ing a single limiting resource S and assume that bacterial growth
on S is proportional to the rate of ATP production with r denoting
the number of cells created per unit of resource and k representing
the measure of affinity for the resource (for details see [82]). We
also make a simplifying assumption that the resource (S0) diffuses
into the system at the same constant rate D as the rate at which
both resources and bacteria are depleted from the system. As
mentioned above these simplifying assumptions regarding the
environment and cell metabolism enable us to isolate the effects of
SPANC balance trade-off on evolution of diversity of RpoS levels
within an E. coli population.
Supporting Information
Figure S1 Statistically significant links between phenotypes. The
links are depicted by a line with the p-value. The sign of the link
(positive in green, phenotypes increase together; or negative in red,
a phenotype increases when the other decreases) is also provided.
The used data set corresponds to 23 isolates originating from 8
patients.
Found at: doi:10.1371/journal.ppat.1001125.s001 (0.22 MB TIF)
Figure S2 Level of RpoS studied by immunoblot in the 7 E. coli
isolates of patient 13 (A) and the 9 E. coli isolates of patient 17 (B).
RpoS amount is expressed as the ratio of the RpoS band to a
constant cross-reactive band. The negative control is E. coli
MG1655 DrpoS strain. Experiments were repeated 2 times, given
values are the mean of the two experiments.
Found at: doi:10.1371/journal.ppat.1001125.s002 (0.89 MB TIF)
Figure S3 2-DE gel image of the mix of protein extracts from
the 8 representative E. coli isolates of patient 3, harvested at the
beginning of stationary phase in LB. Proteins were separated by
analytical 2-DE and detected by colloidal Coomassie blue staining.
The 27 proteins differentially expressed between the 8 isolates are
indicated in red. ND corresponds to the putative outer membrane
protein. The ranges of the pH in the isoelectrofocalisation and of
the molecular weight in the SDS-PAGE are indicated.
Found at: doi:10.1371/journal.ppat.1001125.s003 (1.80 MB TIF)
Figure S4 A schematics of a mathematical model incorporating
the SPANC balance trade-off. The model considers an E. coli
population with n competing strains each with a different value of
the RpoS expression x so that Nxi is the density of a strain with
phenotype xi where i = 1…n and 0= x1#x2#…#xn = 1. Evolu-
tionary changes in x are constrained by the SPANC balance trade-
off in the following way: and increase in xi leads to a decrease in
the maximal resource uptake rate f(xi) and to an increase in stress
protection c(xi). Mutations altering x occur at a rate e.
Found at: doi:10.1371/journal.ppat.1001125.s004 (0.42 MB TIF)
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Table S1 Virulence gene patterns of the E. coli isolates belonging
to the same clone but exhibiting an intra patient diversity in the
virulence gene pattern.
Found at: doi:10.1371/journal.ppat.1001125.s005 (0.18 MB
DOC)
Table S2 Antibiotic resistance patterns of the E. coli isolates.
Found at: doi:10.1371/journal.ppat.1001125.s006 (0.31 MB
DOC)
Table S3 Mutator E. coli isolates identified by monitoring the
isolate capacity to generate mutations conferring resistance to
rifampicin.
Found at: doi:10.1371/journal.ppat.1001125.s007 (0.03 MB
DOC)
Table S4 Biolog GN2 microplate results for the E. coli isolates
from single patients showing an impaired growth.
Found at: doi:10.1371/journal.ppat.1001125.s008 (0.46 MB
DOC)
Acknowledgments
We thank Ivan Matic for constant encouragements all along this work. We
thank Ce´line Henry and Didier Chevret for their help in the MALDI-TOF
analysis.
Author Contributions
Conceived and designed the experiments: ML OZ OC OB CB BP SN IG
OT ED. Performed the experiments: ML OZ OC OB MCH CB CSR FN
TB MZ SC BCWM SN IG KP. Analyzed the data: ML OZ OC OB SL
CB BP FN MZ SC BCWM SN IG TF OT ED. Contributed reagents/
materials/analysis tools: HLN. Wrote the paper: BP SN IG TF OT ED.
References
1. Brogden KA, Guthmiller JM, Taylor CE (2005) Human polymicrobial
infections. Lancet 365: 253–255.
2. Denamur E, Picard B, Goullet P, Bingen E, Lambert N, et al. (1991) Complexity
of Pseudomonas aeruginosa infection in cystic fibrosis: combined results from
esterase electrophoresis and rDNA restriction fragment length polymorphism
analysis. Epidemiol Infect 106: 531–539.
3. Romling U, Fiedler B, Bosshammer J, Grothues D, Greipel J, et al. (1994)
Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis.
J Infect Dis 170: 1616–1621.
4. Pirnay JP, De Vos D, Cochez C, Bilocq F, Pirson J, et al. (2003) Molecular
epidemiology of Pseudomonas aeruginosa colonization in a burn unit:
persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant
clone. J Clin Microbiol 41: 1192–1202.
5. Israel DA, Salama N, Krishna U, Rieger UM, Atherton JC, et al. (2001)
Helicobacter pylori genetic diversity within the gastric niche of a single human
host. Proc Natl Acad Sci U S A 98: 14625–14630.
6. Galdbart JO, Morvan A, Desplaces N, el Solh N (1999) Phenotypic and genomic
variation among Staphylococcus epidermidis strains infecting joint prostheses.
J Clin Microbiol 37: 1306–1312.
7. Van Eldere J, Peetermans WE, Struelens M, Deplano A, Bobbaers H (2000)
Polyclonal Staphylococcal endocarditis caused by genetic variability. Clin Infect
Dis 31: 24–30.
8. Warren RM, Victor TC, Streicher EM, Richardson M, Beyers N, et al. (2004)
Patients with active tuberculosis often have different strains in the same sputum
specimen. Am J Respir Crit Care Med 169: 610–614.
9. Arbeit RD, Slutsky A, Barber TW, Maslow JN, Niemczyk S, et al. (1993)
Genetic diversity among strains of Mycobacterium avium causing monoclonal
and polyclonal bacteremia in patients with AIDS. J Infect Dis 167: 1384–1390.
10. Sharma M, Riederer K, Johnson LB, Khatib R (2001) Molecular analysis of
coagulase-negative Staphylococcus isolates from blood cultures: prevalence of
genotypic variation and polyclonal bacteremia. Clin Infect Dis 33: 1317–1323.
11. Friesen ML, Saxer G, Travisano M, Doebeli M (2004) Experimental evidence
for sympatric ecological diversification due to frequency-dependent competition
in Escherichia coli. Evolution 58: 245–260.
12. Treves DS, Manning S, Adams J (1998) Repeated evolution of an acetate-
crossfeeding polymorphism in long-term populations of Escherichia coli. Mol
Biol Evol 15: 789–797.
13. Rainey PB, Rainey K (2003) Evolution of cooperation and conflict in
experimental bacterial populations. Nature 425: 72–74.
14. Rozen DE, Lenski RE (2000) Long-Term Experimental Evolution in
Escherichia coli. VIII. Dynamics of a Balanced Polymorphism. Am Nat 155:
24–35.
15. Maharjan R, Seeto S, Notley-McRobb L, Ferenci T (2006) Clonal adaptive
radiation in a constant environment. Science 313: 514–517.
16. Ferenci T (2005) Maintaining a healthy SPANC balance through regulatory and
mutational adaptation. Mol Microbiol 57: 1–8.
17. Hengge-Aronis R (2002) Signal transduction and regulatory mechanisms
involved in control of the sigma(S) (RpoS) subunit of RNA polymerase.
Microbiol Mol Biol Rev 66: 373–395, table of contents.
18. Griffin AS, West SA, Buckling A (2004) Cooperation and competition in
pathogenic bacteria. Nature 430: 1024–1027.
19. Deitsch KW, Moxon ER, Wellems TE (1997) Shared themes of antigenic
variation and virulence in bacterial, protozoal, and fungal infections. Microbiol
Mol Biol Rev 61: 281–293.
20. Tenaillon O, Skurnik D, Picard B, Denamur E (2010) The population genetics
of commensal Escherichia coli. Nat Rev Microbiol 8: 207–217.
21. Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev
Microbiol 2: 123–140.
22. Russo TA, Johnson JR (2003) Medical and economic impact of extraintestinal
infections due to Escherichia coli: focus on an increasingly important endemic
problem. Microbes Infect 5: 449–456.
23. Selander RK, Levin BR (1980) Genetic diversity and structure in Escherichia
coli populations. Science 210: 545–547.
24. Desjardins P, Picard B, Kaltenbock B, Elion J, Denamur E (1995) Sex in
Escherichia coli does not disrupt the clonal structure of the population: evidence
from random amplified polymorphic DNA and restriction-fragment-length
polymorphism. J Mol Evol 41: 440–448.
25. Herzer PJ, Inouye S, Inouye M, Whittam TS (1990) Phylogenetic distribution of
branched RNA-linked multicopy single-stranded DNA among natural isolates of
Escherichia coli. J Bacteriol 172: 6175–6181.
26. Escobar-Paramo P, Sabbagh A, Darlu P, Pradillon O, Vaury C, et al. (2004)
Decreasing the effects of horizontal gene transfer on bacterial phylogeny: the
Escherichia coli case study. Mol Phylogenet Evol 30: 243–250.
27. Picard B, Garcia JS, Gouriou S, Duriez P, Brahimi N, et al. (1999) The link
between phylogeny and virulence in Escherichia coli extraintestinal infection.
Infect Immun 67: 546–553.
28. Escobar-Paramo P, Clermont O, Blanc-Potard AB, Bui H, Le Bouguenec C,
et al. (2004) A specific genetic background is required for acquisition and
expression of virulence factors in Escherichia coli. Mol Biol Evol 21: 1085–
1094.
29. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, et al. (1995)
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel
electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:
2233–2239.
30. Lecointre G, Rachdi L, Darlu P, Denamur E (1998) Escherichia coli molecular
phylogeny using the incongruence length difference test. Mol Biol Evol 15:
1685–1695.
31. Johnson JR, Clermont O, Menard M, Kuskowski MA, Picard B, et al. (2006)
Experimental mouse lethality of Escherichia coli isolates, in relation to accessory
traits, phylogenetic group, and ecological source. J Infect Dis 194: 1141–1150.
32. Alekshun MN, Levy SB (2007) Molecular mechanisms of antibacterial multidrug
resistance. Cell 128: 1037–1050.
33. Denamur E, Bonacorsi S, Giraud A, Duriez P, Hilali F, et al. (2002) High
frequency of mutator strains among human uropathogenic Escherichia coli
isolates. J Bacteriol 184: 605–609.
34. Denamur E, Matic I (2006) Evolution of mutation rates in bacteria. Mol
Microbiol 60: 820–827.
35. Tenaillon O, Toupance B, Le Nagard H, Taddei F, Godelle B (1999) Mutators,
population size, adaptive landscape and the adaptation of asexual populations of
bacteria. Genetics 152: 485–493.
36. Zambrano MM, Siegele DA, Almiron M, Tormo A, Kolter R (1993) Microbial
competition: Escherichia coli mutants that take over stationary phase cultures.
Science 259: 1757–1760.
37. Riehle MM, Bennett AF, Long AD (2001) Genetic architecture of thermal
adaptation in Escherichia coli. Proc Natl Acad Sci U S A 98: 525–530.
38. Bochner BR, Gadzinski P, Panomitros E (2001) Phenotype microarrays for high-
throughput phenotypic testing and assay of gene function. Genome Res 11:
1246–1255.
39. King T, Ishihama A, Kori A, Ferenci T (2004) A regulatory trade-off as a source
of strain variation in the species Escherichia coli. J Bacteriol 186: 5614–5620.
40. Robbe-Saule V, Jaumouille V, Prevost MC, Guadagnini S, Talhouarne C, et al.
(2006) Crl activates transcription initiation of RpoS-regulated genes involved in
the multicellular behavior of Salmonella enterica serovar Typhimurium.
J Bacteriol 188: 3983–3994.
41. Romling U (2005) Characterization of the rdar morphotype, a multicellular
behaviour in Enterobacteriaceae. Cell Mol Life Sci 62: 1234–1246.
Within-Patient E. coli Diversity during Infections
PLoS Pathogens | www.plospathogens.org 18 September 2010 | Volume 6 | Issue 9 | e1001125
42. Cooper VS, Schneider D, Blot M, Lenski RE (2001) Mechanisms causing rapid
and parallel losses of ribose catabolism in evolving populations of Escherichia
coli B. J Bacteriol 183: 2834–2841.
43. Waterman SR, Small PL (2003) Transcriptional expression of Escherichia coli
glutamate-dependent acid resistance genes gadA and gadBC in an hns rpoS
mutant. J Bacteriol 185: 4644–4647.
44. Lease RA, Smith D, McDonough K, Belfort M (2004) The small noncoding
DsrA RNA is an acid resistance regulator in Escherichia coli. J Bacteriol 186:
6179–6185.
45. Solnick JV, Hansen LM, Salama NR, Boonjakuakul JK, Syvanen M (2004)
Modification of Helicobacter pylori outer membrane protein expression during
experimental infection of rhesus macaques. Proc Natl Acad Sci U S A 101:
2106–2111.
46. Pluschke G, Mercer A, Kusecek B, Pohl A, Achtman M (1983) Induction of
bacteremia in newborn rats by Escherichia coli K1 is correlated with only
certain O (lipopolysaccharide) antigen types. Infect Immun 39: 599–608.
47. Moxon ER, Murphy PA (1978) Haemophilus influenzae bacteremia and
meningitis resulting from survival of a single organism. Proc Natl Acad Sci U S A
75: 1534–1536.
48. Rubin LG (1987) Bacterial colonization and infection resulting from multipli-
cation of a single organism. Rev Infect Dis 9: 488–493.
49. Margolis E, Levin BR (2007) Within-host evolution for the invasiveness of
commensal bacteria: an experimental study of bacteremias resulting from
Haemophilus influenzae nasal carriage. J Infect Dis 196: 1068–1075.
50. Aleshkin GI, Kadzhaev KV, Markov AP (1998) High and low UV-dose
responses in SOS-induction of the precise excision of transposons tn1, Tn5 and
Tn10 in Escherichia coli. Mutat Res 401: 179–191.
51. Guerin E, Cambray G, Sanchez-Alberola N, Campoy S, Erill I, et al. (2009) The
SOS response controls integron recombination. Science 324: 1034.
52. Soto SM, Jimenez de Anta MT, Vila J (2006) Quinolones induce partial or total
loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-
dependent or -independent pathways, respectively. Antimicrob Agents Che-
mother 50: 649–653.
53. Petersen L, Bollback JP, Dimmic M, Hubisz M, Nielsen R (2007) Genes under
positive selection in Escherichia coli. Genome Res 17: 1336–1343.
54. Sleight SC, Orlic C, Schneider D, Lenski RE (2008) Genetic basis of
evolutionary adaptation by Escherichia coli to stressful cycles of freezing,
thawing and growth. Genetics 180: 431–443.
55. Chesson P (2000) Mechanisms of maintenance of species diversity. Annual
Review of Ecology and Systematics 31: 343–366.
56. Doebeli M, Ispolatov I (2010) Complexity and diversity. Science 328: 494–497.
57. Krogfelt KA, Hjulgaard M, Sorensen K, Cohen PS, Givskov M (2000) rpoS
gene function is a disadvantage for Escherichia coli BJ4 during competitive
colonization of the mouse large intestine. Infect Immun 68: 2518–2524.
58. Fang FC, Libby SJ, Buchmeier NA, Loewen PC, Switala J, et al. (1992) The
alternative sigma factor katF (rpoS) regulates Salmonella virulence. Proc Natl
Acad Sci U S A 89: 11978–11982.
59. West SA, Buckling A (2003) Cooperation, virulence and siderophore production
in bacterial parasites. Proc Biol Sci 270: 37–44.
60. De Vos D, De Chial M, Cochez C, Jansen S, Tummler B, et al. (2001) Study of
pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic
fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of
pyoverdine-negative mutations. Arch Microbiol 175: 384–388.
61. Nogueira T, Rankin DJ, Touchon M, Taddei F, Brown SP, et al. (2009)
Horizontal gene transfer of the secretome drives the evolution of bacterial
cooperation and virulence. Curr Biol 19: 1683–1691.
62. Turner PE, Chao L (1999) Prisoner’s dilemma in an RNA virus. Nature 398:
441–443.
63. Escobar-Paramo P, Grenet K, Le Menac’h A, Rode L, Salgado E, et al. (2004)
Large-scale population structure of human commensal Escherichia coli isolates.
Appl Environ Microbiol 70: 5698–5700.
64. EUCAST (2003) Determination of minimum inhibitory concentrations (MICs)
of antibacterial agents by broth dilution. Clinical Microbiology and Infection 9:
ix–xx.
65. Turnidge JD, Bell JM (2005) Antimicrobial susceptibility on solid media. In:
Wilkins LWa, ed. Antibiotics in laboratory medicine. pp 8–60.
66. Proctor RA (2000) Editorial response: coagulase-negative staphylococcal
infections: A diagnostic and therapeutic challenge. Clin Infect Dis 31: 31–33.
67. Versalovic J, Koeuth T, Lupski JR (1991) Distribution of repetitive DNA
sequences in eubacteria and application to fingerprinting of bacterial genomes.
Nucleic Acids Res 19: 6823–6831.
68. Branger C, Bruneau B, Lesimple AL, Bouvet PJ, Berry P, et al. (1997)
Epidemiological typing of extended-spectrum beta-lactamase-producing Kleb-
siella pneumoniae isolates responsible for five outbreaks in a university hospital.
J Hosp Infect 36: 23–36.
69. Rasheed JK, Jay C, Metchock B, Berkowitz F, Weigel L, et al. (1997) Evolution
of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia
coli during multiple episodes of bacteremia. Antimicrob Agents Chemother 41:
647–653.
70. Angus BL, Carey AM, Caron DA, Kropinski AM, Hancock RE (1982) Outer
membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type
with an antibiotic-supersusceptible mutant. Antimicrob Agents Chemother 21:
299–309.
71. Lespinats S, Verleysen M, Giron A, Fertil B (2007) DD-HDS: A method for
visualization and exploration of high-dimensional data. IEEE Trans Neural
Netw 18: 1265–1279.
72. Waterman SR, Small PL (1996) Characterization of the acid resistance
phenotype and rpoS alleles of shiga-like toxin-producing Escherichia coli. Infect
Immun 64: 2808–2811.
73. Hengge-Aronis R, Fischer D (1992) Identification and molecular analysis of
glgS, a novel growth-phase-regulated and rpoS-dependent gene involved in
glycogen synthesis in Escherichia coli. Mol Microbiol 6: 1877–1886.
74. Coynault C, Robbe-Saule V, Norel F (1996) Virulence and vaccine potential of
Salmonella typhimurium mutants deficient in the expression of the RpoS (sigma
S) regulon. Mol Microbiol 22: 149–160.
75. Damerval C, De Vienne D, Zivy M, Thiellement H (1986) Technical
improvements in two-dimensional electrophoresis increase the level of genetic
variation detected in wheat-seedling proteins. Electrophoresis 7: 52–54.
76. Mechin V, Consoli L, Le Guilloux M, Damerval C (2003) An efficient
solubilization buffer for plant proteins focused in immobilized pH gradients.
Proteomics 3: 1299–1302.
77. Go¨rg A, Postel W, Weser J, Gu¨nther S, Strahler JR, et al. (1987) Elimination of
point streaking on silver stained two-dimensional gels by addition of
iodoacetamide to the equilibration buffer. Electrophoresis 8: 122–124.
78. Mechin V, Balliau T, Chateau-Joubert S, Davanture M, Langella O, et al.
(2004) A two-dimensional proteome map of maize endosperm. Phytochemistry
65: 1609–1618.
79. Vallenet D, Labarre L, Rouy Z, Barbe V, Bocs S, et al. (2006) MaGe: a
microbial genome annotation system supported by synteny results. Nucleic Acids
Res 34: 53–65.
80. Ning Z, Cox AJ, Mullikin JC (2001) SSAHA: a fast search method for large
DNA databases. Genome Res 11: 1725–1729.
81. Zerbino DR, Birney E (2008) Velvet: algorithms for de novo short read assembly
using de Bruijn graphs. Genome Res 18: 821–829.
82. Gudelj I, Beardmore RE, Arkin SS, MacLean RC (2007) Constraints on
microbial metabolism drive evolutionary diversification in homogeneous
environments. J Evol Biol 20: 1882–1889.
83. Collet A, Cosette P, Beloin C, Ghigo JM, Rihouey C, et al. (2008) Impact of
rpoS deletion on the proteome of Escherichia coli grown planktonically and as
biofilm. J Proteome Res 7: 4659–4669.
84. Dong T, Schellhorn HE (2009) Control of RpoS in global gene expression of
Escherichia coli in minimal media. Mol Genet Genomics 281: 19–33.
85. Rahman M, Hasan MR, Oba T, Shimizu K (2006) Effect of rpoS gene knockout
on the metabolism of Escherichia coli during exponential growth phase and
early stationary phase based on gene expressions, enzyme activities and
intracellular metabolite concentrations. Biotechnol Bioeng 94: 585–595.
86. Lacour S, Landini P (2004) SigmaS-dependent gene expression at the onset of
stationary phase in Escherichia coli: function of sigmaS-dependent genes and
identification of their promoter sequences. J Bacteriol 186: 7186–7195.
87. Ishihama A (2000) Functional modulation of Escherichia coli RNA polymerase.
Annu Rev Microbiol 54: 499–518.
Within-Patient E. coli Diversity during Infections
PLoS Pathogens | www.plospathogens.org 19 September 2010 | Volume 6 | Issue 9 | e1001125
